Page 234 - Read Online

188. Buyon JP. The effects of pregnancy on autoimmune diseases. 208. Chen ML, Wu S, Tsai TC, Wang LK, Tsai FM. Regulation
J Leukoc Biol 1998;63:281‑7. of macrophage immune responses by antipsychotic drugs.
189. Ruiz‑Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Immunopharmacol Immunotoxicol 2013;35:573‑80.
Hughes GR, Buchanan NM. Increased rate of lupus flare during 209. de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H,
pregnancy and the puerperium: a prospective study of 78 Kahn RS, Bahn S. Cytokine alterations in first‑episode schizophrenia
pregnancies. Br J Rheumatol 1996;35:133‑8. patients before and after antipsychotic treatment. Schizophr Res
190. Bergink V, Burgerhout KM, Weigelt K, Pop VJ, de Wit H, 2014;154:23‑9.
Drexhage RC, Kushner SA, Drexhage HA. Immune system 210. Hu X, Zhou H, Zhang D, Yang S, Qian L, Wu HM, Chen PS,
dysregulation in first‑onset postpartum psychosis. Biol Psychiatry Wilson B, Gao HM, Lu RB, Hong JS. Clozapine protects
2013;73:1000‑7. dopaminergic neurons from inflammation‑induced damage by
191. Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic inhibiting microglial overactivation. J Neuroimmune Pharmacol
potential of mood stabilizers lithium and valproic acid: beyond 2012;7:187‑201.
bipolar disorder. Pharmacol Rev 2013;65:105‑42. 211. Kato T, Monji A, Hashioka S, Kanba S. Risperidone significantly
192. Nassar A, Azab AN. Effects of Lithium on Inflammation. ACS Chem inhibits interferon‑gamma‑induced microglial activation in vitro.
Neurosci 2014;5:451‑8. Schizophr Res 2007;92:108‑15.
193. Quiroz JA, Machado‑Vieira R, Zarate CA Jr, Manji HK. Novel 212. Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J,
insights into lithium’s mechanism of action: neurotrophic and Lin Z, Fang Y. IL‑23 and TGF‑beta1 levels as potential predictive
neuroprotective effects. Neuropsychobiology 2010;62:50‑60. biomarkers in treatment of bipolar I disorder with acute manic
194. Albayrak A, Halici Z, Polat B, Karakus E, Cadirci E, Bayir Y, Kunak S, episode. J Affect Disord 2015;174:361‑6.
Karcioglu SS, Yigit S, Unal D, Atamanalp SS. Protective effects 213. Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY.
of lithium: a new look at an old drug with potential antioxidative In vivo immunomodulatory effects of clozapine in schizophrenia.
and anti‑inflammatory effects in an animal model of sepsis. Int Schizophr Res 1997;26:221‑5.
Immunopharmacol 2013;16:35‑40. 214. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R,
195. Bosetti F, Rintala J, Seemann R, Rosenberger TA, Contreras MA, Cooremans W, Scharpe S. Acute phase proteins in schizophrenia,
Rapoport SI, Chang MC. Chronic lithium downregulates mania and major depression: modulation by psychotropic drugs.
cyclooxygenase‑2 activity and prostaglandin E (2) concentration Psychiatry Res 1997;66:1‑11.
in rat brain. Mol Psychiatry 2002;7:845‑50. 215. Pollmacher T, Hinze‑Selch D, Mullington J. Effects of clozapine
196. Chang MC, Jones CR. Chronic lithium treatment decreases brain on plasma cytokine and soluble cytokine receptor levels. J Clin
phospholipase A2 activity. Neurochem Res 1998;23:887‑92. Psychopharmacol 1996;16:403‑9.
197. Dong H, Zhang X, Dai X, Lu S, Gui B, Jin W, Zhang S, Zhang S, 216. Roge R, Moller BK, Andersen CR, Correll CU, Nielsen J.
Qian Y. Lithium ameliorates lipopolysaccharide‑induced microglial Immunomodulatory effects of clozapine and their clinical
activation via inhibition of toll‑like receptor 4 expression by activating implications: what have we learned so far? Schizophr Res
the PI3K/Akt/FoxO1 pathway. J Neuroinflammation 2014;11:140. 2012;140:204‑13.
198. Green HF, Nolan YM. GSK‑3 mediates the release of IL‑1beta, 217. Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J,
TNF‑alpha and IL‑10 from cortical glia. Neurochem Int Chen da C, Xiu MH, Kosten TA, Kosten TR. Effects of risperidone
2012;61:666‑71. and haloperidol on superoxide dismutase and nitric oxide in
199. Nahman S, Belmaker RH, Azab AN. Effects of lithium on schizophrenia. Neuropharmacology 2012;62:1928‑34.
lipopolysaccharide‑induced inflammation in rat primary glia cells. 218. Ayorech Z, Tracy DK, Baumeister D, Giaroli G. Taking the fuel out
Innate Immun 2012;18:447‑58. of the fire: evidence for the use of anti‑inflammatory agents in the
200. Boufidou F, Nikolaou C, Alevizos B, Liappas IA, Christodoulou GN. treatment of bipolar disorders. J Affect Disord 2015;174C: 467‑78.
Cytokine production in bipolar affective disorder patients under 219. Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O’Neil A,
lithium treatment. J Affect Disord 2004;82:309‑13. Davey CG, Sanna L, Maes M. Aspirin: a review of its neurobiological
201. Rapaport MH, Manji HK. The effects of lithium on ex vivo cytokine properties and therapeutic potential for mental illness. BMC Med
production. Biol Psychiatry 2001;50:217‑24. 2013;11:74.
202. Rapaport MH, Guylai L, Whybrow P. Immune parameters in 220. Magalhaes PV, Dean OM, Bush AI, Copolov DL, Malhi GS,
rapid cycling bipolar patients before and after lithium treatment. Kohlmann K, Jeavons S, Schapkaitz I, Anderson‑Hunt M, Berk M.
J Psychiatr Res 1999;33:335‑40. A preliminary investigation on the efficacy of N‑acetyl cysteine for
203. Bosetti F, Weerasinghe GR, Rosenberger TA, Rapoport SI. mania or hypomania. Aust N Z J Psychiatry 2013;47:564‑8.
Valproic acid down‑regulates the conversion of arachidonic acid to 221. McNamara RK, Lotrich FE. Elevated immune‑inflammatory
eicosanoids via cyclooxygenase‑1 and ‑2 in rat brain. J Neurochem signaling in mood disorders: a new therapeutic target? Expert Rev
2003;85:690‑6. Neurother 2012;12:1143‑61.
204. Himmerich H, Bartsch S, Hamer H, Mergl R, Schonherr J, 222. Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta‑Soares GB,
Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U. Impact of mood Frey BN, Bowden CL, Soares JC. Celecoxib as an adjunct in the
stabilizers and antiepileptic drugs on cytokine production in‑vitro. treatment of depressive or mixed episodes of bipolar disorder:
J Psychiatr Res 2013;47:1751‑9. a double‑blind, randomized, placebo‑controlled study. Hum
205. Himmerich H, Bartsch S, Hamer H, Mergl R, Schonherr J, Psychopharmacol 2008;23:87‑94.
Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U. Modulation of 223. Begemann M, Sargin D, Rossner MJ, Bartels C, Theis F, Wichert SP,
cytokine production by drugs with antiepileptic or mood stabilizer Stender N, Fischer B, Sperling S, Stawicki S, Wiedl A, Falkai P,
properties in anti‑CD3‑ and anti‑Cd40‑stimulated blood in vitro. Nave KA, Ehrenreich H. Episode‑specific differential gene expression
Oxid Med Cell Longev 2014;2014:806162. of peripheral blood mononuclear cells in rapid cycling supports novel
206. Al‑Amin MM, Nasir Uddin MM, Mahmud Reza H. Effects of treatment approaches. Mol Med 2008;14:546‑52.
antipsychotics on the inflammatory response system of patients 224. Guloksuz S, Altinbas K, Aktas Cetin E, Kenis G, Bilgic Gazioglu S,
with schizophrenia in peripheral blood mononuclear cell cultures. Deniz G, Oral ET, van Os J. Evidence for an association between
Clin Psychopharmacol Neurosci 2013;11:144‑51. tumor necrosis factor‑alpha levels and lithium response. J Affect
207. Bian Q, Kato T, Monji A, Hashioka S, Mizoguchi Y, Horikawa H, Disord 2012;143:148‑52.
Kanba S. The effect of atypical antipsychotics, perospirone, 225. Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A,
ziprasidone and quetiapine on microglial activation induced by Woldeyohannes HO, McIntyre RS. The effect of tumor necrosis
interferon‑gamma. Prog Neuropsychopharmacol Biol Psychiatry factor antagonists on mood and mental health‑associated quality
2008;32:42‑8. of life: novel hypothesis‑driven treatments for bipolar depression?

226 Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015